Are Weight-Loss Drugs Causing Soaring Yogurt Sales?

A New Favorite Snack

Americans have a new favorite snack food: Low-sugar Greek yogurt.

Sales in this segment have grown from $1.9 billion to $2.2 billion over the past year, according to data from yogurt company Chobani, citing Nielsen data. That’s an increase of nearly 18%, blowing overall yogurt sales (+9%) out of the water.

Weight-Loss Is Yogurt’s Gain

So what’s behind this sudden love for dairy? Greek yogurt can be an attractive option for health-conscious consumers looking for something high in protein and low in sugar. But what else is new?

After all, cutting out sugar isn’t a new health trend. In 2023, 72% of Americans reported wanting to limit or cut sugar from their diet, according to the International Food Information Council .

Here’s what has changed: This recent spike of hunger for a healthy snack also coincided with the rising popularity of weight-loss drugs Ozempic and Wegovy, which have helped their manufacturer, Novo Nordisk (NVO), become one of Europe’s most valuable companies.

As the drugs’ popularity skyrocketed, food companies and retailers noted changes in shopping and consumption behavior. Walmart (WMT), for example, made headlines last year for suggesting weight-loss drugs changed its customers’ grocery shopping habits.

So low-sugar Greek yogurt may have benefited from this change in behavior as well.

Looking for more stories like this? Visit On the Money — SoFi’s one-stop-shop for news, trends, and tips!

Check it out

Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi. These links are provided for informational purposes and should not be viewed as an endorsement. No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.
SOSS24022101